Stonebridge Financial Planning Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,340
| Closed | -$241K | – | 127 |
|
|
2022
Q4 | $241K | Buy |
+1,340
| New | +$241K | 0.16% | 111 |
|
|
2022
Q2 | – | Sell |
-1,360
| Closed | -$234K | – | 120 |
|
|
2022
Q1 | $234K | Sell |
1,360
-350
| -20% | -$60.2K | 0.13% | 104 |
|
|
2021
Q4 | $273K | Sell |
1,710
-50
| -3% | -$7.98K | 0.14% | 103 |
|
|
2021
Q3 | $609K | Sell |
1,760
-125
| -7% | -$43.3K | 0.3% | 70 |
|
|
2021
Q2 | $451K | Buy |
1,885
+20
| +1% | +$4.79K | 0.24% | 76 |
|
|
2021
Q1 | $260K | Hold |
1,865
| – | – | 0.15% | 94 |
|
|
2020
Q4 | $195K | Buy |
1,865
+200
| +12% | +$20.9K | 0.12% | 104 |
|
|
2020
Q3 | $123K | Buy |
1,665
+1,265
| +316% | +$93.5K | 0.09% | 119 |
|
|
2020
Q2 | $23K | Buy |
400
+100
| +33% | +$5.75K | 0.02% | 247 |
|
|
2020
Q1 | $10K | Buy |
+300
| New | +$10K | 0.01% | 302 |
|